LPTX - Leap Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LPTX is currently covered by 5 analysts with an average price target of $14.98. This is a potential upside of $12 (402.68%) from yesterday's end of day stock price of $2.98.

Leap Therapeutics's activity chart (see below) currently has 17 price targets and 34 ratings on display. The stock rating distribution of LPTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.19% with an average time for these price targets to be met of 166 days.

Highest price target for LPTX is $5.5, Lowest price target is $5.5, average price target is $14.98.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 15-Nov-2024. First documented stock forecast 12-Apr-2018.

Currently out of the existing stock ratings of LPTX, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5.5

$2.59 (89.00%)

$5.5

1 months 11 days ago
(15-Nov-2024)

0/6 (0%)

$2.75 (100.00%)

Buy

$20

1 years 1 months 6 days ago
(20-Nov-2023)

0/3 (0%)

$15.8 (376.19%)

Buy

1 years 1 months 12 days ago
(14-Nov-2023)

2/4 (50%)

$13.21 (348.55%)

115

Buy

1 years 1 months 12 days ago
(14-Nov-2023)

0/1 (0%)

$33.9 (210.56%)

Buy

1 years 11 months 9 days ago
(17-Jan-2023)

1/3 (33.33%)

$28.9 (260.36%)

669

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LPTX (Leap Therapeutics) average time for price targets to be met?

On average it took 166 days on average for the stock forecasts to be realized with a an average price target met ratio 26.19

Which analyst has the current highest performing score on LPTX (Leap Therapeutics) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on LPTX (Leap Therapeutics) with a proven track record?

JOEL BEATTY

Which analyst has the most public recommendations on LPTX (Leap Therapeutics)?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on LPTX

Which analyst is the currently most bullish on LPTX (Leap Therapeutics)?

Tyler Van Buren with highest potential upside - $3.62

Which analyst is the currently most reserved on LPTX (Leap Therapeutics)?

Joseph Catanzaro with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?